OMER News and Press, Omeros Corporation From 08/10/20

Omeros (NASDAQ: OMER ) : Q2 GAAP EPS of -$0.61 misses by $0.02 . More news on: Omeros Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

Omeros Corporation (Nasdaq: OMER) (“Omeros”) today announced that it has commenced concurrent underwritten public offerings of $125,000,000 of shares of its common stock (the “Shares”) and $200,000,000 aggregate principal amount of convertible senior notes due 2026...

Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of th...

Gainers:  Seres Therapeutics (NASDAQ: MCRB ) +356% . More news on: Seres Therapeutics, Inc., Xtant Medical Holdings, Inc., BiomX Inc., Stocks on the move, , Read more ...

Seres Therapeutics (NASDAQ: MCRB ) +266%  on success of lead drug in C. diff study. More news on: Seres Therapeutics, Inc., Trevena, Inc., Hoth Therapeutics, Inc., Stocks on the move, , Read more ...

Omeros (NASDAQ: OMER ) jumps  45%  premarket on increased volume in reaction to positive results from a compassionate-use study evaluating narsoplimab in severely ill COVID-19 patients with acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. More news...

-- All six patients, requiring mechanical ventilation prior to treatment, recovered, survived and were discharged from the hospital -- Narsoplimab treatment was associated with rapid and sustained improvement across all assessed markers of endothelial/cellular damage and/or inflammatio...

I have been singing the praises of Omeros since my first Omeros ( OMER ) article , "Omeros: Beauty and the Beast", back in March of 2018. At the time I noted Omeros' great attractions: its beauty, against an ominous background: the ever lurking beast. In the intervening time it seems that n...

Many investors have made tons of money by investing in small-cap biotech stocks, especially those that are still relatively obscure. One potential investment candidate that's slipped under the radar due to the coronavirus pandemic is Omeros Corporation (NASDAQ: OMER) . A biotech company that ...

Without education, we are in a horrible and deadly danger of taking educated people seriously. "― G.K. Chesterton Today, we revisit a name we have covered often over the past two years. The company has been maddening for investors as the shares trade at the same level as a year ago...